Britain’s medicines regulator said on Thursday it had approved AstraZeneca’s antibody-based treatment to prevent COVID-19 in people whose immune response is poor.
UK approves AstraZeneca’s antibody-based COVID-19 treatment
Wednesday, July 9, 2025
Britain’s medicines regulator said on Thursday it had approved AstraZeneca’s antibody-based treatment to prevent COVID-19 in people whose immune response is poor.